• Can We really Apply "Precision Medicine" to Infectious Diseases?
  • The impact of Microbiota on human health and in infectious disease
  • From phenotypic to genotypic antibiotic stewardship in microbiological diagnostic: state of the art
  • Epidemiology of multi drug resistance microrganisms in Italy
  • The Italian plan to takle antibiotic resistance
  • Strategies to prevent the risks of infections in LTCFs and geriatric settings
  • New models to improve antibiotic surgical prophylaxis
  • Drug level monitoring for guiding antibiotic and antimicotic individualized treatment
  • Individualized antibiotic therapy of invasive infections due to multidrug-resistant gram negative bacteria
  • Treatment and outcome of MRSA bacteraemia
  • Antimicrobial treatment in the elderly
  • Present and future for HIV care
  • Prevalence, genotype distribution, and risk factors for hepatitis C infection among HIVco-infected individuals
  • HCV and HBV therapy in 2017: current status
  • Present and Future of Infectious Diseases
  • The guidelines for antimicrobial prescription for an individualized treatment in hospital and community settings: opportunities or dangers ?
  • How to organize antimicrobial stewardship in hospital settings
  • Costs evaluation of antibiotic stewardship programs in different health- care settings
  • Management of fungal infections in onco-haematological patients
  • New sepsis definitions and treatment models
  • First experiences with new beta-lactam/beta-lactamase inhibitor combinations,cephalosporin, oxazolidinones and glycopeptides.
  • Pathogenesis and treatment concepts of orthopaedic biofilm infections
  • Diagnosis and treatment of C. difficile: state of the art
  • Decolonization strategies for MDR bacteria: present and future perspectives
  • The pathogenetic role of toxins in skin and soft tissue infections
  • Management of pneumonia in health care and community settings
  • Mycobacteria in migrants population: testing, follow-up and treatment